Asia Pacific

  • Interview: Transforming genetic testing for rare diseases with AI

    Software company 3Billion is innovating genetic testing for rare diseases with AI. Health Tech World speaks to CEO Changwon Keum to find out more. Founded in 2016 as exome and whole genome-based genetic testing services were emerging, 3Billion is harnessing AI to innovate genome interpretation. The company's AI-powered genetic testing diagnoses rare diseases more accurately [...]

  • Interview: World-first handheld device can predict preterm birth risk

    Preterm birth affects one in 10 babies globally, but a first-of-its-kind handheld diagnostic device hopes to transform these outcomes by predicting the risk ahead of time. Health Tech World speaks to Dr Shaolin Liang of Every Baby to find out more. Every hour, 125 babies die from preterm birth complications. This figure reveals a desperate [...]

  • Interview: How BC is blossoming as a global hub of health innovation

    Andrew Mernin meets Wendy Hurlburt, president and CEO of Life Sciences British Columbia (LSBC), to find out more about research, investment and trade opportunities in the vast Canadian province. When we meet Wendy Hulburt on the bustling exhibition floor of one of Asia’s biggest health innovation summits, it is immediately clear that she is a leader in [...]

  • Interview: Advancing drug delivery with ultrasound technology

    Opharmic Technology is advancing targeted drug delivery with the innovative use of ultrasound technology. Health Tech World speaks meets founder Langston Suen in Hong Kong to find out more. Opharmic Technology has developed a non-invasive drug delivery system that harnesses low-frequency ultrasound technology to deliver drugs without invasive needles. Targeting retinal diseases that currently require injection-based treatment, [...]

  • AI health firm Respiree raises US$11.6m Series A

    Health tech company Respiree has raised US$11.6m in Series A funding to expand its AI tools for managing disease progression across care settings. Founded in Singapore, the company said its augmented-AI platform is designed to support clinical decision-making by automating patient monitoring, care pathway management and the delivery of medical insights. One of its key [...]

  • Biostate AI unlocks molecular doors to global health with alliances from Boston to Bengaluru

    Biostate AI has secured strategic research partnerships in the U.S. and India, and a joint venture in China, dramatically expanding the global dataset for their RNA sequencing-based precision medicine solutions. Biostate AI uses RNA sequencing, a snapshot of gene activity, to build AI models that accurately guide drug development, therapy selection and personalised health predictions. [...]

  • From Patient Zero to the world’s largest living patient registry in sickle cell disease

    By Sanius Health It began with one patient. One story. One mission. One urgent need to do better. From that single spark, Sanius Health set out to change the way sickle cell disease is understood, treated and supported. What started as a small mission to accelerate research, discover new medicines, and improve health outcomes has [...]

  • Why collaboration is the watch-word at landmark Asian health innovators gathering

    Health tech leaders, stakeholders, buyers and investors from across the globe gathered in Hong Kong this week to discuss the future of healthcare. The concurrent Asia Summit on Global Health (ASGH) and Medical and Healthcare Fair brought together innovators from all health disciplines under the common theme of ‘fostering global collaboration for a shared future’. [...]

  • Discover investment opportunities & innovation at International Healthcare Week in Hong Kong

    The 4th International Healthcare Week (IHW), driven by the Hong Kong Trade Development Council (HKTDC), will run from 26 May to 15 June 2025 in Hong Kong, helping to promote innovation, investment and exchange by fully utilising Hong Kong’s strategic role as an innovation and investment hub for Asia’s healthcare industry. The two flagship events [...]

  • health.tech returns with bold new vision through joint venture between MCH Group and Bits & Pretzels

    MCH Group, the Swiss-based global experience marketing leader, and Bits & Pretzels, Europe’s premier founder platform, today announced a strategic joint venture to relaunch the health.tech event on 3-5 March 2026.  The event, to be held in Basel, Switzerland, will bring together the most influential voices across the European and UK healthcare value chain—startups, scale-ups, [...]